IMID

Immune-mediated inflammatory diseases

Immune-mediated
Immune Mediated inflammatory Disease (IMID) is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response. All IMIDs can cause end organ damage, and are associated with increased morbidity and/or mortality. Inflammation is an important and growing area of biomedical research and health care because inflammation mediates and is the primary driver of many medical disorders and autoimmune diseases, including ankylosing spondylitis, psoriasis, psoriatic arthritis, Behcet's disease, arthritis, inflammatory bowel disease (IBD), autistic enterocolitis, and allergy, as well as many cardiovascular, neuromuscular, and infectious diseases...

IMID - List of case studies

IgG Multiple Myeloma

inhibitors carfilzomib or salinosporamide ; the new IMID , pomalidomide ; histone deacetylase inhibitors such as LAQ824 ... proteasome inhibitors, carfilzomib, salinosporamide, IMID, pomalidomide, histone deacetylase inhibitors, LAQ824, LBH589, tubacin, ...

Drugs

drug I IGF1 IL-2 fusion proteins IMID INSULIN LANTUS SOLOSTAR INSULIN NOVORAPID FLEX PEN ITAB ...

JustAnswer.com